Michael Morse

7PUBLICATIONS
27CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 19, 2025
CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity.

Bin-Jin Hwang, Erika J Crosby, David T Severson

|May 20, 2025
Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians.

Dimitrios Moris, Alessandro Martinino, Sarah Schiltz

|Feb 11, 2025
Phase Ib/II study of Pembrolizumab with Lanreotide depot for advanced, progressive Gastroenteropancreatic neuroendocrine tumors (PLANET).

Michael A Morse, Erika J Crosby, Daniel M Halperin

|Dec 23, 2022
Mechanisms of Resistance in Gastroenteropancreatic Neuroendocrine Tumors.

Chanjuan Shi, Michael A Morse

|Jan 29, 2021
Vaccine Therapies for Cancer: Then and Now.

Michael A Morse, William R Gwin, Duane A Mitchell

Pageof 2